BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30550941)

  • 1. Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.
    Sabhachandani P; Sarkar S; Mckenney S; Ravi D; Evens AM; Konry T
    J Control Release; 2019 Feb; 295():21-30. PubMed ID: 30550941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mini-pillar array for hydrogel-supported 3D culture and high-content histologic analysis of human tumor spheroids.
    Kang J; Lee DW; Hwang HJ; Yeon SE; Lee MY; Kuh HJ
    Lab Chip; 2016 Jun; 16(12):2265-76. PubMed ID: 27194205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening.
    Chen MC; Gupta M; Cheung KC
    Biomed Microdevices; 2010 Aug; 12(4):647-54. PubMed ID: 20237849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy.
    Foxall R; Narang P; Glaysher B; Hub E; Teal E; Coles MC; Ashton-Key M; Beers SA; Cragg MS
    Front Immunol; 2020; 11():605231. PubMed ID: 33628205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and functional assessment of 3D multicellular spheroids in droplet based microfluidics platform.
    Sabhachandani P; Motwani V; Cohen N; Sarkar S; Torchilin V; Konry T
    Lab Chip; 2016 Feb; 16(3):497-505. PubMed ID: 26686985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alginate core-shell beads for simplified three-dimensional tumor spheroid culture and drug screening.
    Yu L; Ni C; Grist SM; Bayly C; Cheung KC
    Biomed Microdevices; 2015 Apr; 17(2):33. PubMed ID: 25681969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic co-culture of liver tumor spheroids with stellate cells for the investigation of drug resistance and intercellular interactions.
    Chen Y; Sun W; Kang L; Wang Y; Zhang M; Zhang H; Hu P
    Analyst; 2019 Jul; 144(14):4233-4240. PubMed ID: 31210202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotaxis-driven assembly of endothelial barrier in a tumor-on-a-chip platform.
    Aung A; Theprungsirikul J; Lim HL; Varghese S
    Lab Chip; 2016 May; 16(10):1886-98. PubMed ID: 27097908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
    Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
    Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
    LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB
    Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droplet-based microfluidic system for multicellular tumor spheroid formation and anticancer drug testing.
    Yu L; Chen MC; Cheung KC
    Lab Chip; 2010 Sep; 10(18):2424-32. PubMed ID: 20694216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
    Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
    Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uniform sized cancer spheroids production using hydrogel-based droplet microfluidics: a review.
    Kim S; Lam PY; Jayaraman A; Han A
    Biomed Microdevices; 2024 May; 26(2):26. PubMed ID: 38806765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term fluorescence hyperspectral imaging of on-chip treated co-culture tumour spheroids to follow clonal evolution.
    St-Georges-Robillard A; Cahuzac M; Péant B; Fleury H; Lateef MA; Ricard A; Sauriol A; Leblond F; Mes-Masson AM; Gervais T
    Integr Biol (Camb); 2019 Apr; 11(4):130-141. PubMed ID: 31172192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
    Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
    Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid spheroid clearing on a microfluidic chip.
    Silva Santisteban T; Rabajania O; Kalinina I; Robinson S; Meier M
    Lab Chip; 2017 Dec; 18(1):153-161. PubMed ID: 29192297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid formation of size-controllable multicellular spheroids via 3D acoustic tweezers.
    Chen K; Wu M; Guo F; Li P; Chan CY; Mao Z; Li S; Ren L; Zhang R; Huang TJ
    Lab Chip; 2016 Jul; 16(14):2636-43. PubMed ID: 27327102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep learning unlocks label-free viability assessment of cancer spheroids in microfluidics.
    Chiang CC; Anne R; Chawla P; Shaw RM; He S; Rock EC; Zhou M; Cheng J; Gong YN; Chen YC
    Lab Chip; 2024 Jun; 24(12):3169-3182. PubMed ID: 38804084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
    Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
    Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.